1. Home
  2. VIR vs FNKO Comparison

VIR vs FNKO Comparison

Compare VIR & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • FNKO
  • Stock Information
  • Founded
  • VIR 2016
  • FNKO 2017
  • Country
  • VIR United States
  • FNKO United States
  • Employees
  • VIR N/A
  • FNKO N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • FNKO Recreational Games/Products/Toys
  • Sector
  • VIR Health Care
  • FNKO Consumer Discretionary
  • Exchange
  • VIR Nasdaq
  • FNKO Nasdaq
  • Market Cap
  • VIR 844.9M
  • FNKO 708.1M
  • IPO Year
  • VIR 2019
  • FNKO 2017
  • Fundamental
  • Price
  • VIR $5.41
  • FNKO $4.20
  • Analyst Decision
  • VIR Strong Buy
  • FNKO Strong Buy
  • Analyst Count
  • VIR 7
  • FNKO 3
  • Target Price
  • VIR $33.57
  • FNKO $13.33
  • AVG Volume (30 Days)
  • VIR 1.0M
  • FNKO 1.0M
  • Earning Date
  • VIR 05-07-2025
  • FNKO 05-08-2025
  • Dividend Yield
  • VIR N/A
  • FNKO N/A
  • EPS Growth
  • VIR N/A
  • FNKO N/A
  • EPS
  • VIR N/A
  • FNKO N/A
  • Revenue
  • VIR $20,861,000.00
  • FNKO $1,049,850,000.00
  • Revenue This Year
  • VIR N/A
  • FNKO $3.25
  • Revenue Next Year
  • VIR $10.65
  • FNKO $8.30
  • P/E Ratio
  • VIR N/A
  • FNKO N/A
  • Revenue Growth
  • VIR N/A
  • FNKO N/A
  • 52 Week Low
  • VIR $4.95
  • FNKO $3.79
  • 52 Week High
  • VIR $14.45
  • FNKO $14.65
  • Technical
  • Relative Strength Index (RSI)
  • VIR 35.98
  • FNKO 36.98
  • Support Level
  • VIR $5.83
  • FNKO $3.79
  • Resistance Level
  • VIR $6.29
  • FNKO $4.22
  • Average True Range (ATR)
  • VIR 0.31
  • FNKO 0.28
  • MACD
  • VIR 0.02
  • FNKO 0.18
  • Stochastic Oscillator
  • VIR 28.80
  • FNKO 55.41

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About FNKO Funko Inc.

Funko Inc is an us-based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

Share on Social Networks: